132088 <common-name>Peforelin</common-name> <description nil="true"/> <cas>147859-97-0</cas> <pubchem-id>56841717</pubchem-id> <chemical-formula>C59H75N19O13</chemical-formula> <weight nil="true"/> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-04-06T17:00:21Z</created-at> <updated-at type="dateTime">2026-05-14T20:43:50Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id>DB21255</drugbank-id> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>NCCCC[C@H](NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@H](CO)NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CC1=CNC=N1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O</moldb-smiles> <moldb-formula>C59H75N19O13</moldb-formula> <moldb-inchi>InChI=1S/C59H75N19O13/c60-16-6-5-12-40(59(91)78-17-7-13-47(78)58(90)65-27-49(62)81)71-52(84)41(20-33-18-31-8-1-3-10-37(31)68-33)74-56(88)45(24-48(61)80)76-54(86)44(23-36-26-64-30-67-36)75-57(89)46(28-79)77-55(87)42(21-34-19-32-9-2-4-11-38(32)69-34)73-53(85)43(22-35-25-63-29-66-35)72-51(83)39-14-15-50(82)70-39/h1-4,8-11,18-19,25-26,29-30,39-47,68-69,79H,5-7,12-17,20-24,27-28,60H2,(H2,61,80)(H2,62,81)(H,63,66)(H,64,67)(H,65,90)(H,70,82)(H,71,84)(H,72,83)(H,73,85)(H,74,88)(H,75,89)(H,76,86)(H,77,87)/t39-,40-,41-,42-,43-,44-,45-,46-,47-/m0/s1</moldb-inchi> <moldb-inchikey>QMAOBPTXTXJMIM-CSYZDTNESA-N</moldb-inchikey> <moldb-average-mass type="decimal">1258.369</moldb-average-mass> <moldb-mono-mass type="decimal">1257.579174</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp nil="true"/> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM127981</chemdb-id> <dsstox-id>DTXSID30163819</dsstox-id> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id>NS00134305</susdat-id> <iupac>5-Oxo-L-prolyl-L-histidyl-3-(1H-indol-2-yl)-L-alanyl-L-seryl-L-histidyl-L-asparaginyl-3-(1H-indol-2-yl)-L-alanyl-L-lysyl-L-prolylglycinamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> </compound>